IBR Is Deemed Okay After Mastectomy

NOVEMBER 01, 2004

Reporting in the Archives of Surgery (September 2004), researchers found that women who undergo mastectomy for breast cancer also can have immediate breast reconstruction (IBR) at the time of surgery without delaying chemotherapy, if this treatment also is needed. The researchers noted, however, that this option is not without risks. Specifically, the risks include wound complications, which could delay chemotherapy, possibly jeopardizing the patient's chance for survival.

In the current study, the researchers analyzed data from 128 women with breast cancer (62 of whom underwent IBR and 66 of whom did not). The women had a total of 148 mastectomies at the UC Davis Medical Center in Sacramento, Calif. The rate of wound complications (eg, infection and bleeding) was 22% in the IBR group, compared with 8% in the comparison group. Even with the increased rate of wound complications, IBR did not impede the start of chemotherapy. Of all the participants, only 2 patients in each group started chemotherapy later than 4 to 6 weeks after surgery. That time frame is when most physicians prefer to begin a course of treatment.



SHARE THIS SHARE THIS
0

Become A RESPIMAT T.O.P. Performer 

Get to know RESPIMAT, the slow-moving mist inhaler from Boehringer Ingelheim Pharmaceuticals, Inc.

Watch the RESPIMAT video and test your knowledge with a short multiple-choice quiz. When you get all the answers right, you’ll receive a certificate naming you a RESPIMAT T.O.P. Performer. Why not check it out today?


Pharmacy Times Strategic Alliance
 

Pharmacist Education
Clinical features with downloadable PDFs


Next-Generation Pharmacist® Awards


3rd Annual Convenient Healthcare and Pharmacy Collaborative Conference


SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.